CLINICAL BENEFITS AND THERAPEUTIC PERSPECTIVES OF PERIOPERATIVEIMMUNOCHEMOTHERAPY IN LUNG CANCER

Abstract

Lung cancer is the leading cause of cancer mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases. We present the case of a 70-year-old patient who underwent thoracic echography due to periodic dyspnea, which revealed a tumor formation in the right lung along the midclavicular line measuring 4/3 cm, followed by a Tru-Cut biopsy. The clinical case described demonstrates an excellent response in a patient with non-small cell locally advanced lung cancer treated with immunotherapy and chemotherapy preoperatively. The data from the clinical studies presented highlight the potential of the combined approach and significantly improve the frequency of complete pathological response.